摘要:
An organic electroluminescent device comprising an anode, a cathode, a light emitting layer that is disposed between the anode and the cathode and contains a first light emitting layer material containing a phosphorescent compound and a second light emitting layer material containing a charge transporting polymer compound (that is, a light emitting layer containing a first light emitting layer material and a second light emitting layer material), and a hole transporting layer that is disposed between the anode and the light emitting layer so as to be adjacent to the light emitting layer and is composed of a hole transporting polymer compound, wherein the lowest excitation triplet energy T1 e (eV) of the first light emitting layer material, the lowest excitation triplet energy T1 h (eV) of the second light emitting layer material and the lowest excitation triplet energy T1 t (eV) of the hole transporting polymer compound satisfy the following formulae (A) and (B):
An organic electroluminescent device comprising an anode and a cathode, and a hole transporting layer and a light emitting layer disposed between the anode and the cathode, wherein the hole transporting layer contains 1) a mixture of 2,2'-bipyridine and/or 2,2'-bipyridine derivative and a non-2,2'-bipyridinediyl group-containing hole transporting polymer compound, 2) a 2,2'-bipyridinediyl group-containing polymer compound having a constitutional unit composed of an unsubstituted or substituted 2,2'-bipyridinediyl group, and at least one constitutional unit selected from the group consisting of constitutional units composed of a divalent aromatic amine residue and constitutional units composed of an unsubstituted or substituted arylene group, or a combination thereof.
摘要:
Disclosed is a novel sphingosine compound having a sphingomyelinase inhibitory activity. Also disclosed is a method for producing such a sphingosine compound. The novel sphingosine compound is represented by the following general formula (1). (1) (In the formula, one of R1 and R2 represents a hydrogen atom and the other represents a group represented by the following formula (G): (G) ; n represents 0 or 1; and R3 represents a hydrogen atom, a C1-23 alkyl group, a C3-8 cycloalkyl group, a C2-6 alkenyl group, a C1-6 alkoxy group, a C3-8 cycloalkyloxy group, a phenyl group or a furyl group.)
摘要:
A polymer compound having a residue of a compound represented by the following formula (1):
wherein Ar represents an aryl group or mono-valent heterocyclic group.) and a residue of a compound represented by the following formula (2) :
wherein one member of Z 1 to Z 3 represents -N= and two remainders thereof each represent -C(R')=. Z 4 and Z 5 each represent -C(R')=. One member of Z 6 to Z 8 represents -N= and two remainders thereof each represent -C(R')=. Z 9 and Z 10 each represent -C(R')=. R' represents a hydrogen atom, alkyl group or the like).
摘要翻译:具有由下式(1)表示的化合物的残基的高分子化合物:其中Ar表示芳基或1价杂环基)和由下式(2)表示的化合物的残基:其中一个成员 Z 1〜Z 3表示-N =,且其余数分别表示-C(R')=。 Z 4和Z 5各自表示-C(R')=。 Z 6至Z 8的一个成员表示-N =,其余两个表示-C(R')=。 Z 9和Z 10各自表示-C(R')=。 R'表示氢原子,烷基等)。
摘要:
The invention relates to a method for producing onium alkyl sulfates by reacting an onium halogenide with a symmetrically substituted dialkyl sulfate, the alkyl group thereof containing between 1 and 14 C atoms, with an unsymmetrically substituted dialkyl sulfate, one alkyl group containing between 4 and 20 C atoms, and the second alkyl group being methyl or ethyl, with an alkyl-trialkylsilyl sulfate, with an alkylacyl sulfate, or with an alkylsulfonyl sulfate, the reaction with the dialkyl sulphate taking place at room temperature.
摘要:
The invention is directed to bipyridine-based compounds and organic light emitting diodes (OLED) including organic layers comprising the bipyridine-based compound. OLEDs including organic layers comprising the bipyridine-based compounds have low driving voltages, high current densities, high efficiencies and long lifetimes.
摘要:
The present invention relates to compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing the compounds of the invention and intermediate compounds useful in these processes.
摘要:
The invention relates to a method for producing onium alkyl sulfates by reacting an onium halogenide with a symmetrically substituted dialkyl sulfate, the alkyl group thereof containing between 1 and 14 C atoms, with an unsymmetrically substituted dialkyl sulfate, one alkyl group containing between 4 and 20 C atoms, and the second alkyl group being methyl or ethyl, with an alkyl-trialkylsilyl sulfate, with an alkylacyl sulfate, or with an alkylsulfonyl sulfate, the reaction with the dialkyl sulphate taking place at room temperature.
摘要:
The invention relates to a series of compounds useful for inhibiting histone deacetylase (HDAC) enzymatic activity. The invention also provides a method for inhibiting histone descetylase in a cell using said compounds as well as a method for treating cell proliferative diseases and conditions using said HDAC inhibitors. Further, the invention provides pharmaceutical compositions comprising the HDAC inhibiting compounds and a pharmaceutically acceptable carrier.
摘要:
The present invention is directed to isotopically labeled alkyne derivative compounds, particularly 11C, 13C, 14C, 18F, 15O, 13N, 35S, 2H, and 3H labeled compounds. In particular, the present invention is directed to 11C, 13C, 14C, 18F, 15O, 13N, 35S, 2H, and 3H labeled heterocyclic alkynes and methods of their preparation. The present invention further includes a method of use of the 11C, 18F, 15O, or 13N labeled heterocyclic alkyne compounds as tracers in positron emission tomography (PET) imaging, particularly in the study of metabolic conditions in mammals, specifically conditions modulated by metabotropic glutamate receptors subtype 5 (mGluR5).